Merck's Isentress Approved for All Adult HIV Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
Isentress in combination therapy has less effect on lipid levels than standard of care Sustiva-based therapy in HIV treatment naïve patients, study shows.